Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Sarcoma, Synovial|Sarcoma,Soft Tissue|Melanoma Stage IV|Triple Negative Breast Cancer|Metastatic Cancer|Non Small Cell Lung Cancer|Bladder Urothelial Carcinoma|Neuroblastoma, Metastatic|Ovary Cancer
Interventions: DRUG: CYCLOPHOSPHAMIDE and FLUDARABIN|DRUG: Cyclophosphamide|BIOLOGICAL: HBI 0201-ESO TCRT|DRUG: Aldesleukin
Sponsor: Hadassah Medical Organization